Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Emerging β-amyloid pathology and accelerated cortical atrophy.
Mattsson N, Insel PS, Nosheny R, Tosun D, Trojanowski JQ, Shaw LM, Jack CR Jr, Donohue MC, Weiner MW; Alzheimer’s Disease Neuroimaging Initiative. Mattsson N, et al. Among authors: donohue mc. JAMA Neurol. 2014 Jun;71(6):725-34. doi: 10.1001/jamaneurol.2014.446. JAMA Neurol. 2014. PMID: 24781145 Free PMC article.
Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials.
Donohue MC, Moghadam SH, Roe AD, Sun CK, Edland SD, Thomas RG, Petersen RC, Sano M, Galasko D, Aisen PS, Rissman RA. Donohue MC, et al. Alzheimers Dement. 2015 Sep;11(9):1069-79. doi: 10.1016/j.jalz.2014.07.156. Epub 2014 Oct 7. Alzheimers Dement. 2015. PMID: 25301682 Free PMC article. Clinical Trial.
The transitional association between β-amyloid pathology and regional brain atrophy.
Insel PS, Mattsson N, Donohue MC, Mackin RS, Aisen PS, Jack CR Jr, Shaw LM, Trojanowski JQ, Weiner MW; Alzheimer's Disease Neuroimaging Initiative. Insel PS, et al. Among authors: donohue mc. Alzheimers Dement. 2015 Oct;11(10):1171-9. doi: 10.1016/j.jalz.2014.11.002. Epub 2014 Dec 9. Alzheimers Dement. 2015. PMID: 25499535 Free PMC article.
Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease.
Insel PS, Mattsson N, Mackin RS, Kornak J, Nosheny R, Tosun-Turgut D, Donohue MC, Aisen PS, Weiner MW; Alzheimer's Disease Neuroimaging Initiative. Insel PS, et al. Among authors: donohue mc. Ann Clin Transl Neurol. 2015 May;2(5):534-47. doi: 10.1002/acn3.192. Epub 2015 Mar 21. Ann Clin Transl Neurol. 2015. PMID: 26000325 Free PMC article.
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.
Toledo JB, Zetterberg H, van Harten AC, Glodzik L, Martinez-Lage P, Bocchio-Chiavetto L, Rami L, Hansson O, Sperling R, Engelborghs S, Osorio RS, Vanderstichele H, Vandijck M, Hampel H, Teipl S, Moghekar A, Albert M, Hu WT, Monge Argilés JA, Gorostidi A, Teunissen CE, De Deyn PP, Hyman BT, Molinuevo JL, Frisoni GB, Linazasoro G, de Leon MJ, van der Flier WM, Scheltens P, Blennow K, Shaw LM, Trojanowski JQ; Alzheimer’s Disease Neuroimaging Initiative. Toledo JB, et al. Brain. 2015 Sep;138(Pt 9):2701-15. doi: 10.1093/brain/awv199. Epub 2015 Jul 27. Brain. 2015. PMID: 26220940 Free PMC article.
151 results